Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US58933Y1055
Ticker MRK
Company MERCK & CO. INC
Currency $
Price
Aware Investor Index (AII) 1.4540
Recommendation BUY
P/E 30.05
ROE 13.96 %
Capitalization 187,733,280,000 $
Dividend Yield 2.74 %
P/S 4.75
AII Position 222
P/E Position 392
ROE Position 276
Capitalization Position 37
Dividend Yield Position 210
Sales 39,498,000,000 $
10-Year Average Earnings 6,248,280,000 $
Shares Outstanding 2,841,000,000
Equity 44,767,000,000 $
Dividend per Share 1.81 $
Industry Pharmaceutical
Country United States
MERCK & CO. INC Investor Relations Web Site http://www.merck.com/investors/home.html







Sales:

YEAR MONTH AMOUNT
2015 12 39,498,000,000.00 $
2014 12 42,237,000,000.00 $
2013 12 44,033,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 4,442,000,000.00 $
2014 12 11,920,000,000.00 $
2013 12 4,404,000,000.00 $
2012 12 6,168,000,000.00 $
2011 12 6,272,000,000.00 $
2010 12 861,000,000.00 $
2009 12 12,899,000,000.00 $
2008 12 7,808,000,000.00 $
2007 12 3,275,000,000.00 $
2006 12 4,433,800,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 44,767,000,000.00 $
2014 12 48,791,000,000.00 $
2013 12 52,326,000,000.00 $
2012 12 55,463,000,000.00 $
2011 12 56,943,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 2,841,000,000
2014 12 2,928,000,000
2013 12 2,996,000,000
2012 12 3,076,000,000
2011 12 3,094,000,000

 












Bloomberg News for MERCK & CO. INC:

May 1, 2017
U.S. Stocks Advance After Congress Averts Government Shutdown
Capital Corp (PNW), Ecolab Inc (ECL), Eaton Corp PLC (ETN), ConocoPhillips (COP), Merck & Co Inc (MRK), Pfizer Inc (PFE), CVS Health Corp (CVS), Xylem Inc/NY (XYL), Charter Communications Inc (CHTR)...
Mar 21, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
5000 TGB TASEKO MINE TGB US 05/21/11 C6 -10.4 49.5 0.45 -10.0 325 MRK MERCK & CO MRK US 04/16/11 C34 -10.4 18.0 0.14 27.3 1329 EEM ISHARES-EMG EEM US 04/16/11...
Aug 12, 2011
Korea Investment Corporation Holdings in 2nd Quarter: 13F Alert
(USD $) Position In Position Merck & Co. Inc. MRK US 44,902,996 1,272,400 1,272,400 Cia De Minas Buenaventur-ADR BVN US 6,900...
Jun 16, 2011
When Two Cancer Drugs Are Better Than One
sales annually comprise the single biggest pharmaceutical segment. Merck (MRK) and AstraZeneca (AZN) in 2009 became the first rivals to join forces to test two experimental...
May 16, 2011
Orbimed Advisors LLC Holdings in 1st Quarter: 13F Alert
SHPGY US 105,367,221 1,210,700 -45,100 Merck & Co. Inc. MRK US 82,690,050 2,505,000 -791,500 Warner Chilcott Plc-Class A WCRX US 72,036...
May 16, 2011
New York State Teachers Holdings in 1st Quarter: 13F Alert
Inc CSCO US -66,826,266 16,154,759 -843,777 Merck & Co. Inc. MRK US -42,693,240 9,027,379 -425,646 Procter & Gamble Co/The PG US -40,782...
Dec 13, 2010
Adidas, BMW, Deutsche Boerse, Douglas: German Equity Preview
Chief Executive Officer Klaus Probst. The shares advanced 6 percent to 33.87 euros. Merck KGaA (MRK GY): The drugmaker won’t renew the contract of Elmar Schnee, head of the pharmaceuticals business...
Jul 22, 2008
Vytorin: A Setback for Merck and Schering
Merck (MRK) and Schering-Plough (SGP) are taking another big hit. The two drug giants once thought they had a blockbuster in their jointly marketed drug, Vytorin. The drug combines two cholesterol-lowering...
Jul 22, 2008
Big Pharma: What Safe Haven?
drug Vytorin performed poorly in a clinical trial. The news also pushed down shares of Merck (MRK), which co-markets Vytorin. The share declines underscored the risks of flocking to pharmaceutical...
Nov 9, 2007
What Merck Gains by Settling
On Nov. 9 pharmaceutical giant Merck (MRK) said it would pay $4.85 billion to settle 27,000 lawsuits over its drug Vioxx, a painkiller pulled from the market in 2004 after it was linked to heart...


Google News for MERCK & CO. INC:

Yahoo News - 6 days ago
Trump Lashes Out at Merck & Co., Inc. (MRK), But Does It Matter?
Then, Merck & Co., Inc. (NYSE:MRK) CEO Kenneth Frazier resigned from a federal manufacturing council over the weekend's events, and ...
StockNewsJournal - 2 days ago
Taking a Fresh Look at Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been ...
TrueBlueTribune
Revenue Approximations Analysis: Merck & Co., Inc. (MRK), Allison ...
Merck & Co., Inc. (NYSE:MRK) gained 0.32% with the closing price of $62.70. The overall volume in the last trading session was 6.05 million ...
AppsforPCdaily
Momentum Stock: Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK) share price fell -0.5% to $62.18 in the last trading session. The Market Cap of the company is $172.06 Billion.
Week Herald
Checking the Overall Picture for Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been ...
StockNewsJournal - 3 days ago
Martin Shkreli Calls Merck CEO Ken Frazier 'Self-Indulgent,' 'Pathetic'
"Pharma bro" Martin Shkreli has some harsh words for Merck & Co., Inc. (NYSE: MRK)'s CEO Ken Frazier after the executive distanced himself ...
TRA - 11 Aug 2017
Buy or Sell? What Analysts Recommends: MetLife, Inc. (MET), Merck ...
Merck & Co., Inc. (NYSE:MRK) ended its day at $62.50 with the rising stream of -0.27% and its total traded volume was 6.29 million shares less ...
ExpressNewsline
Merck & Co., Inc. (NYSE:MRK): What are The Ratio's Saying About ...
The Current Ratio of Merck & Co., Inc. (NYSE:MRK) is 1.50. The Current Ratio is used by investors to determine whether a company can pay ...
USA Commerce Daily
Merck & Co., Inc. (MRK) stock price of $62.70
Merck & Co., Inc. (MRK)'s Bullish picture have been built after taking the consideration of last five trading activity. Shares of Merck & Co., Inc.
Sports Perspectives
Just the Facts on Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been ...


Back